Randolph Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-336,500
Closed -$12.9M 40
2016
Q3
$12.9M Hold
336,500
3.24% 17
2016
Q2
$14.1M Hold
336,500
3.62% 18
2016
Q1
$13.5M Buy
336,500
+30,200
+10% +$1.21M 3.01% 21
2015
Q4
$13.1M Sell
306,300
-19,150
-6% -$881K 3.33% 18
2015
Q3
$15.4M Hold
325,450
3.7% 13
2015
Q2
$16.1M Hold
325,450
3.64% 12
2015
Q1
$16.1M Buy
+325,450
New +$15.6M 3.49% 15

Other funds holding SNY

Randolph Company's SNY Position: Q4 2016 in Review

Randolph Company sold out of Sanofi (SNY) in Q4 2016, closing a stake of 336,500 shares — an estimated $12.9M sold.

Randolph Company first reported a position in SNY in Q1 2015 and held it in 7 quarters. The position peaked at $16.1M in Q2 2015. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

  • Randolph Company reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
  • Randolph Company sold 336,500 Sanofi shares in Q4 2016, an estimated $12.9M.
  • Randolph Company first reported a position in Sanofi in Q1 2015 and held it in 7 quarters.
  • Randolph Company's Sanofi position peaked at $16.1M in Q2 2015.
  • 476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on Randolph Company's 13F filing for Q4 2016, filed 31 Jan 2017.